MicroPort CardioFlow Medtech Corporation (2160.HK)
MicroPort CardioFlow Medtech Corporation, researches, develops, manufactures, and sells medical devices for the treatment of structural heart disease and cardiac rhythm management in China, Europe, the Middle East, Africa, Asia, North America, and internationally.
1.12+0.01%Healthcare
StockGlow Score
Leaning Bearish
BearishBullish
1 year ago-82.6%
The outlook
MicroPort CardioFlow Medtech Corporation currently reads as leaning bearish based on below its 50- & 200-day averages, 3% of the way from its 52-week low to high, avg target +514% vs current price. This is a snapshot of current market data, not a forecast.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range3% of the way from its 52-week low to high
Price targetAvg target +514% vs current price
Analyst price target
~12-month · 2 analysts6.88average target+513.9% vs now
Now 1.12
Low 6.26High 7.49
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$1.43B
52-wk high
8.45
52-wk low
0.93
50-day avg
1.39
200-day avg
3.71
Trailing P/E
—